These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22028896)

  • 1. Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases.
    Neri P; Tokoro S; Kobayashi R; Sugiyama T; Umeda K; Shimizu T; Tsuji T; Kodama Y; Oguma K; Mori H
    PLoS One; 2011; 6(10):e26526. PubMed ID: 22028896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Shiga toxin B subunit can induce neutralizing immunoglobulin Y antibody.
    Neri P; Tokoro S; Sugiyama T; Umeda K; Shimizu T; Tsuji T; Kodama Y; Mori H
    Biol Pharm Bull; 2012; 35(6):917-23. PubMed ID: 22687484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of egg yolk antibody (IgY) against shiga-like toxin (stx) and evaluation of its prophylaxis potency in mice.
    Fathi J; Ebrahimi F; Nazarian S; Hajizade A; Malekzadegan Y; Abdi A
    Microb Pathog; 2020 Aug; 145():104199. PubMed ID: 32320733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Shiga toxin-producing Escherichia coli by sandwich enzyme-linked immunosorbent assay using chicken egg yolk IgY antibodies.
    Parma YR; Chacana PA; Lucchesi PM; Rogé A; Granobles Velandia CV; Krüger A; Parma AE; Fernández-Miyakawa ME
    Front Cell Infect Microbiol; 2012; 2():84. PubMed ID: 22919675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: isolation, purification and neutralization efficacy.
    Parma YR; Chacana PA; Rogé A; Kahl A; Cangelosi A; Geoghegan P; Lucchesi PM; Fernández-Miyakawa ME
    Toxicon; 2011 Sep; 58(4):380-8. PubMed ID: 21803069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models.
    Wang Q; Hou XJ; Cai K; Li T; Liu YN; Tu W; Xiao L; Bao SZ; Shi J; Gao X; Liu H; Tian RM; Wang H
    Can J Microbiol; 2010 Dec; 56(12):1003-10. PubMed ID: 21164570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection.
    Mukherjee J; Chios K; Fishwild D; Hudson D; O'Donnell S; Rich SM; Donohue-Rolfe A; Tzipori S
    Infect Immun; 2002 Feb; 70(2):612-9. PubMed ID: 11796590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice.
    Liou JF; Chang CW; Tailiu JJ; Yu CK; Lei HY; Chen LR; Tai C
    Vaccine; 2010 Nov; 28(51):8189-96. PubMed ID: 20937321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of egg yolk antibody against shiga toxin II variant toxicity in vitro and in vivo.
    Feng Y; Liu W; Shi D
    Curr Microbiol; 2013 Oct; 67(4):448-53. PubMed ID: 23689941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins.
    Neri P; Nagano SI; Yokoyama S; Dohi H; Kobayashi K; Miura T; Inazu T; Sugiyama T; Nishida Y; Mori H
    Microbiol Immunol; 2007; 51(6):581-92. PubMed ID: 17579269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin suppresses noncanonical inflammasome responses to cytosolic LPS.
    Havira MS; Ta A; Kumari P; Wang C; Russo AJ; Ruan J; Rathinam VA; Vanaja SK
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33246946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Shiga toxin 2e-specific chicken egg yolk immunoglobulin: production and neutralization activity.
    Arimitsu H; Sasaki K; Kohda T; Shimizu T; Tsuji T
    Microbiol Immunol; 2014 Nov; 58(11):643-8. PubMed ID: 25175999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of mice against Shiga toxin 2 (Stx2)-associated damage by maternal immunization with a Brucella lumazine synthase-Stx2 B subunit chimera.
    Mejias MP; Cabrera G; Fernández-Brando RJ; Baschkier A; Ghersi G; Abrey-Recalde MJ; Miliwebsky E; Meiss R; Goldbaum F; Zylberman V; Rivas M; Palermo MS
    Infect Immun; 2014 Apr; 82(4):1491-9. PubMed ID: 24421050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
    Bentancor LV; Mejías MP; Pinto A; Bilen MF; Meiss R; Rodriguez-Galán MC; Baez N; Pedrotti LP; Goldstein J; Ghiringhelli PD; Palermo MS
    mBio; 2013 Oct; 4(5):e00501-13. PubMed ID: 24085779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nasal vaccine comprising B-subunit derivative of Shiga toxin 2 for cross-protection against Shiga toxin types 1 and 2.
    Tsuji T; Shimizu T; Sasaki K; Tsukamoto K; Arimitsu H; Ochi S; Shimizu T; Taniguchi K; Noda M; Neri P; Mori H
    Vaccine; 2008 Apr; 26(17):2092-9. PubMed ID: 18387720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced immunogenicity of a novel Stx2Am-Stx1B fusion protein in a mice model of enterohemorrhagic Escherichia coli O157:H7 infection.
    Cai K; Gao X; Li T; Wang Q; Hou X; Tu W; Xiao L; Tian M; Liu Y; Wang H
    Vaccine; 2011 Jan; 29(5):946-52. PubMed ID: 21134452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous and intranasal immunization with Stx2B-Tir-Stx1B-Zot reduces colonization and shedding of Escherichia coli O157:H7 in mice.
    Zhang XH; He KW; Zhang SX; Lu WC; Zhao PD; Luan XT; Ye Q; Wen LB; Li B; Guo RL; Wang XM; Lv LX; Zhou JM; Yu ZY; Mao AH
    Vaccine; 2011 May; 29(22):3923-9. PubMed ID: 21338683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice.
    Gu J; Ning Y; Wang H; Xiao D; Tang B; Luo P; Cheng Y; Jiang M; Li N; Zou Q; Mao X
    Vaccine; 2011 Oct; 29(43):7395-403. PubMed ID: 21807051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rabbit polyclonal sera against recombinant Shiga toxin and its subunits for detection of Stx-producing E. coli.
    Oloomi M; Bouzari S
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):41-6. PubMed ID: 21358014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella enterica serovar Typhimurium vaccine strains expressing a nontoxic Shiga-like toxin 2 derivative induce partial protective immunity to the toxin expressed by enterohemorrhagic Escherichia coli.
    Rojas RL; Gomes PA; Bentancor LV; Sbrogio-Almeida ME; Costa SO; Massis LM; Ferreira RC; Palermo MS; Ferreira LC
    Clin Vaccine Immunol; 2010 Apr; 17(4):529-36. PubMed ID: 20147499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.